⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

April 30, 2018British journal of surgeryOpen Access

Meta-analysis comparing upfront surgery with neoadjuvant treatment in patients with resectable or borderline resectable pancreatic cancer

Eva Versteijne Jantien A. Vogel Marc G. Besselink Olivier R. Busch Johanna W. Wilmink Joost G. Daams Casper H.J. van Eijck Bas Groot Koerkamp C. Rasch Geertjan van Tienhoven

View Full Paper

Ask AI

Bookmark

Share

Abstract

Neoadjuvant treatment appears to improve overall survival by intention to treat, despite lower overall resection rates for resectable or borderline resectable pancreatic cancer. PROSPERO registration number: CRD42016049374.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Versteijne et al. (2018) studied this question.

synapsesocial.com/papers/69d8b3e88cb8f39931ae39d9 https://doi.org/10.1002/bjs.10870

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trialHuman Clinical Trial · 2017 · 1,931 citations
2CONKO-005: Adjuvant Chemotherapy With Gemcitabine Plus Erlotinib Versus Gemcitabine Alone in Patients After R0 Resection of Pancreatic Cancer: A Multicenter Randomized Phase III TrialRCT · 2017 · 293 citations
3The Impact of Curative Intent Surgery on the Survival of Pancreatic Cancer Patients: A U.S. Population-Based StudyCohort Study · 2007 · 132 citations
4The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaborationMeta-Analysis · 2009 · 17,623 citations
5The Cochrane Collaboration's tool for assessing risk of bias in randomised trialsRisk Assessment · 2011 · 33,724 citations

More related papers

Preoperative/Neoadjuvant Therapy in Pancreatic Cancer: A Systematic Review and Meta-analysis of Response and Resection Percentages2010
Neoadjuvant chemoradiation therapy with gemcitabine/cisplatin and surgery versus immediate surgery in resectable pancreatic cancer2014
Inverse Probability of Treatment Weighting Analysis of Upfront Surgery Versus Neoadjuvant Chemoradiotherapy Followed by Surgery for Pancreatic Adenocarcinoma with Arterial Abutment2015

More from British journal of surgery

Shared data-driven risk language in surgical oncologyThu,
Preoperative risk factor and risk score analysis to predict critical complications and death following pancreatoduodenetcomySat,